{"transactions":[{"id":5069,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-09-04T23:54:13.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":2705,"price":43.6618,"value":118105.169,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sales price. Sale prices for the transactions range from $43.475 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":133048,"source":{"system":"sec-edgar","filing":"0001649245-26-000009","document":"wk-form4_1788566051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1649245/000164924526000009/wk-form4_1788566051.xml","form_type":"4"}},{"id":5068,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-09-04T23:54:13.000Z","date":"2026-09-04","kind":"sale","planned":true,"acquired":false,"shares":10405,"price":42.8933,"value":446304.7865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price. Sale prices for the transactions range from $42.47 to $43.47. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":135753,"source":{"system":"sec-edgar","filing":"0001649245-26-000009","document":"wk-form4_1788566051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1649245/000164924526000009/wk-form4_1788566051.xml","form_type":"4"}},{"id":5067,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-09-04T23:54:13.000Z","date":"2026-09-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":3639,"price":44.88,"value":163318.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does not represent a sale."}],"balance_after":146158,"source":{"system":"sec-edgar","filing":"0001649245-26-000009","document":"wk-form4_1788566051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1649245/000164924526000009/wk-form4_1788566051.xml","form_type":"4"}},{"id":749309,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-06-05T01:38:34.000Z","date":"2026-06-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":3730,"price":47.8,"value":178294.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale."}],"balance_after":149797,"source":{"system":"sec-edgar","filing":"0001649245-26-000007","document":"wk-form4_1780623512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924526000007/wk-form4_1780623512.xml","form_type":"4"}},{"id":850462,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:10:19.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":6578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock units awarded on March 6, 2026 vest in full on the first anniversary of the date of grant subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":153527,"source":{"system":"sec-edgar","filing":"0001649245-26-000006","document":"wk-form4_1773177016.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924526000006/wk-form4_1773177016.xml","form_type":"4"}},{"id":850461,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-03-10T21:10:19.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":29603,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 6, 2026 vest 25% on March 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":146949,"source":{"system":"sec-edgar","filing":"0001649245-26-000006","document":"wk-form4_1773177016.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924526000006/wk-form4_1773177016.xml","form_type":"4"}},{"id":860932,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:16:46.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":13425,"price":36.1586,"value":485429.205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $35.78 to $36.65.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":117346,"source":{"system":"sec-edgar","filing":"0001649245-26-000004","document":"wk-form4_1772659004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924526000004/wk-form4_1772659004.xml","form_type":"4"}},{"id":860931,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:16:46.000Z","date":"2026-03-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":6035,"price":36.01,"value":217320.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale."}],"balance_after":130771,"source":{"system":"sec-edgar","filing":"0001649245-26-000004","document":"wk-form4_1772659004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924526000004/wk-form4_1772659004.xml","form_type":"4"}},{"id":873669,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:52:56.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":24486,"price":38.75,"value":948832.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale."}],"balance_after":136806,"source":{"system":"sec-edgar","filing":"0001649245-26-000002","document":"wk-form4_1772488374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924526000002/wk-form4_1772488374.xml","form_type":"4"}},{"id":873668,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:52:56.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":71806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units (\"PSUs\") on February 26, 2026, upon the certification by the\nBoard of Directors of the Issuer of the achievement of the performance goals set forth therein. Of such PSUs, 47,863 PSUs vested on February 26, 2026, and the remaining 23,943 will vest on December 2, 2026, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":161292,"source":{"system":"sec-edgar","filing":"0001649245-26-000002","document":"wk-form4_1772488374.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924526000002/wk-form4_1772488374.xml","form_type":"4"}},{"id":980050,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-12-05T00:44:29.000Z","date":"2025-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2955,"price":46.16,"value":136402.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on December 2, 2025 and does not represent a sale."}],"balance_after":89486,"source":{"system":"sec-edgar","filing":"0001649245-25-000007","document":"wk-form4_1764895467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924525000007/wk-form4_1764895467.xml","form_type":"4"}},{"id":1021998,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:27:55.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":8349,"price":36.0174,"value":300709.2726,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $35.82 to $36.28.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":92441,"source":{"system":"sec-edgar","filing":"0001649245-25-000005","document":"wk-form4_1759868872.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000164924525000005/wk-form4_1759868872.xml","form_type":"4"}},{"id":1047646,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-09-04T21:13:43.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2955,"price":30.11,"value":88975.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale."}],"balance_after":100790,"source":{"system":"sec-edgar","filing":"0001384101-25-000116","document":"wk-form4_1757020419.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000116/wk-form4_1757020419.xml","form_type":"4"}},{"id":1122494,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-06-04T21:00:49.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":2955,"price":26.74,"value":79016.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 1,688 and 1,267 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,324 and 2,494\nRestricted Stock Units, respectively, granted on October 2, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person."}],"balance_after":103745,"source":{"system":"sec-edgar","filing":"0001384101-25-000068","document":"wk-form4_1749070838.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000068/wk-form4_1749070838.xml","form_type":"4"}},{"id":1214653,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-03-10T20:44:13.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":24160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":106700,"source":{"system":"sec-edgar","filing":"0001384101-25-000044","document":"wk-form4_1741639446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000044/wk-form4_1741639446.xml","form_type":"4"}},{"id":1219207,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-03-06T21:42:05.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":3570,"price":33.9511,"value":121205.427,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sales price.  Sale prices for the transactions range from $33.56 to $34.42.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":82540,"source":{"system":"sec-edgar","filing":"0001384101-25-000032","document":"wk-form4_1741297319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000032/wk-form4_1741297319.xml","form_type":"4"}},{"id":1219206,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-03-06T21:42:05.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":4467,"price":32.8649,"value":146807.5083,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $32.50 to $33.33.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":86110,"source":{"system":"sec-edgar","filing":"0001384101-25-000032","document":"wk-form4_1741297319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000032/wk-form4_1741297319.xml","form_type":"4"}},{"id":1235338,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:33.000Z","date":"2025-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6754,"price":34.76,"value":234769.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person is reporting the withholding of 1,688 and 5,066 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 3,323 and 9,976\nRestricted Stock Units, respectively, granted on October 2, 2023 and March 6, 2024, respectively, and does not represent a sale by the reporting person."}],"balance_after":90577,"source":{"system":"sec-edgar","filing":"0001384101-25-000024","document":"wk-form4_1741037425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000024/wk-form4_1741037425.xml","form_type":"4"}},{"id":1235337,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:33.000Z","date":"2025-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":15672,"price":33.84,"value":530340.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of the PSUs and does not represent a sale."}],"balance_after":97331,"source":{"system":"sec-edgar","filing":"0001384101-25-000024","document":"wk-form4_1741037425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000024/wk-form4_1741037425.xml","form_type":"4"}},{"id":1235336,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2025-03-03T21:30:33.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":30589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock acquired by the Reporting Person upon vesting of certain performance based restricted stock units (\"PSUs\") on February 27, 2025, upon the certification by the Board of Directors of the Issuer of the achievement of the performance goals set forth therein."}],"balance_after":113003,"source":{"system":"sec-edgar","filing":"0001384101-25-000024","document":"wk-form4_1741037425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410125000024/wk-form4_1741037425.xml","form_type":"4"}},{"id":1340204,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2024-12-06T21:34:53.000Z","date":"2024-12-04","kind":"sale","planned":true,"acquired":false,"shares":3934,"price":44.0893,"value":173447.3062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sales price.  Sale prices for the transactions range from $43.60 to $44.46.  Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request."}],"balance_after":82414,"source":{"system":"sec-edgar","filing":"0001384101-24-000186","document":"wk-form4_1733520886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000186/wk-form4_1733520886.xml","form_type":"4"}},{"id":1342628,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2024-12-04T21:59:18.000Z","date":"2024-12-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6738,"price":44.12,"value":297280.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of 6,738 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 13,295 Restricted Stock Units granted on October 2, 2023 and does not represent a sale by the reporting person."}],"balance_after":86348,"source":{"system":"sec-edgar","filing":"0001384101-24-000179","document":"wk-form4_1733349551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000179/wk-form4_1733349551.xml","form_type":"4"}},{"id":1586161,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2024-03-08T21:36:24.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":39904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":93086,"source":{"system":"sec-edgar","filing":"0001384101-24-000036","document":"wk-form4_1709933775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410124000036/wk-form4_1709933775.xml","form_type":"4"}},{"id":1764989,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-10-04T20:35:03.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":85858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable as to 25% of the shares on October 2, 2024, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter."}],"balance_after":85858,"derivative":{"exercise_price":21.96,"expiration_date":"2033-10-02","underlying":"Common Stock","underlying_shares":85858},"source":{"system":"sec-edgar","filing":"0001384101-23-000155","document":"wk-form4_1696451687.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000155/wk-form4_1696451687.xml","form_type":"4"}},{"id":1764988,"issuer":{"id":2018,"kind":"organization","name":"VERACYTE, INC.","symbol":"VCYT"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific & Med Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:35:03.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":53182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Restricted stock units awarded on October 2, 2023 vest 25% on December 2, 2024 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date."}],"balance_after":53182,"source":{"system":"sec-edgar","filing":"0001384101-23-000155","document":"wk-form4_1696451687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410123000155/wk-form4_1696451687.xml","form_type":"4"}},{"id":1975199,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2023-03-03T16:14:34.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":4534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 28, 2025. The number of shares issued will range from 0% to 175% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 28, 2025, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."}],"balance_after":4534,"derivative":{"expiration_date":"2025-12-28","underlying":"Common Stock","underlying_shares":4534},"source":{"system":"sec-edgar","filing":"0001127602-23-008575","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760223008575/form4.xml","form_type":"4"}},{"id":1975198,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2023-03-03T16:14:34.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":3023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."}],"balance_after":3023,"derivative":{"expiration_date":"2024-12-29","underlying":"Common Stock","underlying_shares":3023},"source":{"system":"sec-edgar","filing":"0001127602-23-008575","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760223008575/form4.xml","form_type":"4"}},{"id":1975197,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-03-03T16:14:34.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":7556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2023, November 5, 2024, November 5, 2025, and November 5, 2026, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":14786,"source":{"system":"sec-edgar","filing":"0001127602-23-008575","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760223008575/form4.xml","form_type":"4"}},{"id":1996468,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2023-02-23T22:34:51.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":3522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020."}],"balance_after":0,"derivative":{"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":3522},"source":{"system":"sec-edgar","filing":"0001127602-23-006823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760223006823/form4.xml","form_type":"4"}},{"id":1996467,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T22:34:51.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":1245,"price":202.84,"value":252535.8,"ownership":{"direct":true},"balance_after":7230,"source":{"system":"sec-edgar","filing":"0001127602-23-006823","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760223006823/form4.xml","form_type":"4"}},{"id":1996466,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-23T22:34:51.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":3522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020."}],"balance_after":8475,"source":{"system":"sec-edgar","filing":"0001127602-23-006823","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760223006823/form4.xml","form_type":"4"}},{"id":2122488,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-11-08T22:01:32.000Z","date":"2022-11-05","kind":"tax_withholding","acquired":false,"shares":821,"price":217.19,"value":178312.99,"ownership":{"direct":true},"balance_after":4953,"source":{"system":"sec-edgar","filing":"0001127602-22-025123","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222025123/form4.xml","form_type":"4"}},{"id":2301724,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-04-07T20:19:52.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":1988,"price":360.01,"value":715699.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."}],"balance_after":5774,"source":{"system":"sec-edgar","filing":"0001127602-22-011725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222011725/form4.xml","form_type":"4"}},{"id":2301723,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-04-07T20:19:52.000Z","date":"2022-04-05","kind":"tax_withholding","acquired":false,"shares":131,"price":363.84,"value":47663.04,"ownership":{"direct":true},"balance_after":7762,"source":{"system":"sec-edgar","filing":"0001127602-22-011725","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222011725/form4.xml","form_type":"4"}},{"id":2355875,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2022-03-03T23:28:51.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":9085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 29, 2024. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending December 29, 2024, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."}],"balance_after":9085,"derivative":{"expiration_date":"2024-12-29","underlying":"Common Stock","underlying_shares":9085},"source":{"system":"sec-edgar","filing":"0001127602-22-008112","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222008112/form4.xml","form_type":"4"}},{"id":2355874,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-03T23:28:51.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":3029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2022, November 5, 2023, November 5, 2024, and November 5, 2025, subject to the awardee's continuing status as a service provider on such dates."}],"balance_after":7893,"source":{"system":"sec-edgar","filing":"0001127602-22-008112","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222008112/form4.xml","form_type":"4"}},{"id":2375480,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2022-02-24T22:32:21.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":2851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018."}],"balance_after":0,"derivative":{"expiration_date":"2022-01-02","underlying":"Common Stock","underlying_shares":2851},"source":{"system":"sec-edgar","filing":"0001127602-22-006616","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222006616/form4.xml","form_type":"4"}},{"id":2375479,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-24T22:32:21.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":1002,"price":319.86,"value":320499.72,"ownership":{"direct":true},"balance_after":4864,"source":{"system":"sec-edgar","filing":"0001127602-22-006616","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222006616/form4.xml","form_type":"4"}},{"id":2375478,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-24T22:32:21.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":2851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2018."}],"balance_after":5866,"source":{"system":"sec-edgar","filing":"0001127602-22-006616","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760222006616/form4.xml","form_type":"4"}},{"id":2520035,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-09T21:59:19.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":1000,"price":406.83,"value":406830.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."}],"balance_after":3015,"source":{"system":"sec-edgar","filing":"0001127602-21-028723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221028723/form4.xml","form_type":"4"}},{"id":2520034,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-11-09T21:59:19.000Z","date":"2021-11-05","kind":"tax_withholding","acquired":false,"shares":446,"price":408.14,"value":182030.44,"ownership":{"direct":true},"balance_after":4015,"source":{"system":"sec-edgar","filing":"0001127602-21-028723","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221028723/form4.xml","form_type":"4"}},{"id":2670607,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-14T21:50:56.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":290,"price":449.02,"value":130215.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."}],"balance_after":4461,"source":{"system":"sec-edgar","filing":"0001127602-21-019827","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221019827/form4.xml","form_type":"4"}},{"id":2670606,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-14T21:50:56.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":400,"price":447.65,"value":179060.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Weighted average sale price representing 400 shares sold ranging from $447.28 to $448.02 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request."}],"balance_after":4751,"source":{"system":"sec-edgar","filing":"0001127602-21-019827","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221019827/form4.xml","form_type":"4"}},{"id":2670605,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-06-14T21:50:56.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":310,"price":446.17,"value":138312.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average sale price representing 310 shares sold ranging from $446.14 to $446.24 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request."}],"balance_after":5151,"source":{"system":"sec-edgar","filing":"0001127602-21-019827","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221019827/form4.xml","form_type":"4"}},{"id":2747861,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-16T19:56:48.000Z","date":"2021-04-15","kind":"disposition_to_issuer","acquired":false,"shares":1022,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1022},"source":{"system":"sec-edgar","filing":"0001127602-21-013920","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760221013920/form4.xml","form_type":"4"}},{"id":2747860,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-16T19:56:48.000Z","date":"2021-04-15","kind":"disposition_to_issuer","acquired":false,"shares":1699,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to merger agreement (the \"Merger Agreement\") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-013920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760221013920/form4.xml","form_type":"4"}},{"id":2754608,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-04-07T20:38:52.000Z","date":"2021-04-05","kind":"tax_withholding","acquired":false,"shares":131,"price":384.54,"value":50374.74,"ownership":{"direct":true},"balance_after":5461,"source":{"system":"sec-edgar","filing":"0001127602-21-013414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221013414/form4.xml","form_type":"4"}},{"id":2851065,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2021-02-18T21:44:07.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017."}],"balance_after":0,"derivative":{"expiration_date":"2021-01-03","underlying":"Common Stock","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001127602-21-006514","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221006514/form4.xml","form_type":"4"}},{"id":2851064,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-18T21:44:07.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":1454,"price":494.24,"value":718624.96,"ownership":{"direct":true},"balance_after":5592,"source":{"system":"sec-edgar","filing":"0001127602-21-006514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221006514/form4.xml","form_type":"4"}},{"id":2851063,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-18T21:44:07.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of stock awarded as a result of the Company achieving at least 100% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017."}],"balance_after":7046,"source":{"system":"sec-edgar","filing":"0001127602-21-006514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221006514/form4.xml","form_type":"4"}},{"id":2851062,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-18T21:44:07.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents additional shares of stock awarded as a result of the Company achieving at least 111% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on December 11, 2017."}],"balance_after":3873,"source":{"system":"sec-edgar","filing":"0001127602-21-006514","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221006514/form4.xml","form_type":"4"}},{"id":2856983,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-02-17T19:06:51.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":1225,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1225},"source":{"system":"sec-edgar","filing":"0001127602-21-006368","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760221006368/form4.xml","form_type":"4"}},{"id":2856982,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-17T19:06:51.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":1225,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."}],"balance_after":1699,"source":{"system":"sec-edgar","filing":"0001127602-21-006368","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760221006368/form4.xml","form_type":"4"}},{"id":2861108,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-02-16T08:27:53.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":1022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the earlier of February 15, 2022, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date."}],"balance_after":1022,"derivative":{"underlying":"Common Stock","underlying_shares":1022},"source":{"system":"sec-edgar","filing":"0001127602-21-005592","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760221005592/form4.xml","form_type":"4"}},{"id":2867133,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2021-02-11T23:44:00.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":4140,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending December 31, 2023. The number of shares issued will range from 0% to 175% of the amount specified above, based on the Company's actual earnings per share for the fiscal year ending December 31,2023, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."}],"balance_after":4140,"derivative":{"expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":4140},"source":{"system":"sec-edgar","filing":"0001127602-21-005282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221005282/form4.xml","form_type":"4"}},{"id":2867132,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-11T23:44:00.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":1380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2021, November 5, 2022, November 5, 2023, and November 5, 2024, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":3523,"source":{"system":"sec-edgar","filing":"0001127602-21-005282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760221005282/form4.xml","form_type":"4"}},{"id":2988468,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-11-09T22:35:54.000Z","date":"2020-11-06","kind":"sale","acquired":false,"shares":155,"price":310.1,"value":48065.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."}],"balance_after":2143,"source":{"system":"sec-edgar","filing":"0001127602-20-028496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760220028496/form4.xml","form_type":"4"}},{"id":2988467,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-11-09T22:35:54.000Z","date":"2020-11-05","kind":"tax_withholding","acquired":false,"shares":192,"price":311.72,"value":59850.24,"ownership":{"direct":true},"balance_after":2298,"source":{"system":"sec-edgar","filing":"0001127602-20-028496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760220028496/form4.xml","form_type":"4"}},{"id":3173164,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-20T21:39:24.000Z","date":"2020-04-16","kind":"sale","acquired":false,"shares":173,"price":300,"value":51900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."}],"balance_after":2490,"source":{"system":"sec-edgar","filing":"0001127602-20-014142","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760220014142/form4.xml","form_type":"4"}},{"id":3180869,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-04-07T20:32:14.000Z","date":"2020-04-05","kind":"tax_withholding","acquired":false,"shares":92,"price":278.01,"value":25576.92,"ownership":{"direct":true},"balance_after":2663,"source":{"system":"sec-edgar","filing":"0001127602-20-013391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760220013391/form4.xml","form_type":"4"}},{"id":3265449,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-02-19T19:29:03.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":1225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest on the earlier of February 14, 2021, or the next Annual Meeting of Stockholders that occurs after the Grant Date. Vested shares will be delivered to the reporting person on vest date."}],"balance_after":1225,"derivative":{"underlying":"Common Stock","underlying_shares":1225},"source":{"system":"sec-edgar","filing":"0001127602-20-006589","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760220006589/form4.xml","form_type":"4"}},{"id":3265448,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-02-19T19:29:03.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest immediately on grant date of February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest immediately on grant date of February 14, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":474},"source":{"system":"sec-edgar","filing":"0001127602-20-006589","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760220006589/form4.xml","form_type":"4"}},{"id":3265447,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-02-19T19:29:03.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":474,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest immediately on grant date of February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest immediately on grant date of February 14, 2020."}],"balance_after":474,"derivative":{"underlying":"Common Stock","underlying_shares":474},"source":{"system":"sec-edgar","filing":"0001127602-20-006589","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760220006589/form4.xml","form_type":"4"}},{"id":3265446,"issuer":{"id":140252,"kind":"organization","name":"VARIAN MEDICAL SYSTEMS INC","symbol":"VAR"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-19T19:29:03.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":474,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":474,"source":{"system":"sec-edgar","filing":"0001127602-20-006589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203527/000112760220006589/form4.xml","form_type":"4"}},{"id":3284883,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Performance Shares","published_at":"2020-02-07T22:49:38.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":3746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 1, 2023. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 1, 2023, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":3746,"derivative":{"expiration_date":"2023-01-01","underlying":"Common Stock","underlying_shares":3746},"source":{"system":"sec-edgar","filing":"0001127602-20-004396","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760220004396/form4.xml","form_type":"4"}},{"id":3284882,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-07T22:49:38.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":1249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 5, 2021, February 5, 2022, February 5, 2023 and February 5, 2024, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":2755,"source":{"system":"sec-edgar","filing":"0001127602-20-004396","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760220004396/form4.xml","form_type":"4"}},{"id":3368765,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-18T21:33:17.000Z","date":"2019-11-14","kind":"sale","acquired":false,"shares":155,"price":300,"value":46500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was made pursuant to a 10b5-1 plan."}],"balance_after":1506,"source":{"system":"sec-edgar","filing":"0001127602-19-033040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760219033040/form4.xml","form_type":"4"}},{"id":3377831,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"officer":true,"officer_title":"SVP Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-11-07T21:51:19.000Z","date":"2019-11-05","kind":"tax_withholding","acquired":false,"shares":83,"price":300.87,"value":24972.21,"ownership":{"direct":true},"balance_after":1661,"source":{"system":"sec-edgar","filing":"0001127602-19-032212","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760219032212/form4.xml","form_type":"4"}},{"id":4040943,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T16:19:56.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":300,"price":33.35,"value":10005.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $33.34 to $33.36."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes an aggregate of 21,387 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":21387,"source":{"system":"sec-edgar","filing":"0001209191-18-012405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919118012405/doc4.xml","form_type":"4"}},{"id":4040942,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-22T16:19:56.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":4642,"price":32.8059,"value":152284.9878,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $32.34 to $33.32."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes an aggregate of 21,387 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":21687,"source":{"system":"sec-edgar","filing":"0001209191-18-012405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919118012405/doc4.xml","form_type":"4"}},{"id":4048233,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-20T17:57:32.000Z","date":"2018-02-15","kind":"tax_withholding","acquired":false,"shares":2801,"price":32.66,"value":91480.66,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 21,387 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":26329,"source":{"system":"sec-edgar","filing":"0001209191-18-011496","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919118011496/doc4.xml","form_type":"4"}},{"id":4079565,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2018-02-02T19:32:38.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":26060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as to 25% of the shares on January 31, 2019, and becomes exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":26060,"derivative":{"exercise_price":33.21,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":26060},"source":{"system":"sec-edgar","filing":"0001209191-18-007216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919118007216/doc4.xml","form_type":"4"}},{"id":4079564,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-02T19:32:38.000Z","date":"2018-01-31","kind":"grant","acquired":true,"shares":11330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units awarded on January 31, 2018 which vest as to 1/3 of the shares on each of February 15, 2019, 2020 and 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":29130,"source":{"system":"sec-edgar","filing":"0001209191-18-007216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919118007216/doc4.xml","form_type":"4"}},{"id":4125178,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2017-12-20T16:35:36.000Z","date":"2017-12-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable as to 25% of the shares on February 16, 2017, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":9710,"derivative":{"exercise_price":27,"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001209191-17-066649","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117066649/doc4.xml","form_type":"4"}},{"id":4125177,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-20T16:35:36.000Z","date":"2017-12-19","kind":"sale","acquired":false,"shares":334,"price":36.82,"value":12297.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents actual sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17800,"source":{"system":"sec-edgar","filing":"0001209191-17-066649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117066649/doc4.xml","form_type":"4"}},{"id":4125176,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-20T16:35:36.000Z","date":"2017-12-19","kind":"sale","acquired":false,"shares":5000,"price":37,"value":185000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents actual sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":18134,"source":{"system":"sec-edgar","filing":"0001209191-17-066649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117066649/doc4.xml","form_type":"4"}},{"id":4125175,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-20T16:35:36.000Z","date":"2017-12-19","kind":"exercise","acquired":true,"shares":5000,"price":27,"value":135000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23134,"source":{"system":"sec-edgar","filing":"0001209191-17-066649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117066649/doc4.xml","form_type":"4"}},{"id":4253352,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-21T16:20:40.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":330,"price":33.57,"value":11078.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents actual sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17800,"source":{"system":"sec-edgar","filing":"0001209191-17-045945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117045945/doc4.xml","form_type":"4"}},{"id":4253351,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-21T16:20:40.000Z","date":"2017-07-19","kind":"sale","acquired":false,"shares":2844,"price":33.5654,"value":95459.9976,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents weighted average sale price. Actual sale prices ranged from $33.31 to $33.80."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":18130,"source":{"system":"sec-edgar","filing":"0001209191-17-045945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117045945/doc4.xml","form_type":"4"}},{"id":4439874,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-17T18:44:25.000Z","date":"2017-02-16","kind":"sale","acquired":false,"shares":1226,"price":30.6289,"value":37551.0314,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $30.36 to $31.02."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":20644,"source":{"system":"sec-edgar","filing":"0001209191-17-012364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117012364/doc4.xml","form_type":"4"}},{"id":4439873,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-17T18:44:25.000Z","date":"2017-02-16","kind":"sale","acquired":false,"shares":1269,"price":29.5613,"value":37513.2897,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 22, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $29.25 to $29.95."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":21870,"source":{"system":"sec-edgar","filing":"0001209191-17-012364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117012364/doc4.xml","form_type":"4"}},{"id":4439872,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-17T18:44:25.000Z","date":"2017-02-15","kind":"tax_withholding","acquired":false,"shares":1910,"price":31.12,"value":59439.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 17,800 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23139,"source":{"system":"sec-edgar","filing":"0001209191-17-012364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117012364/doc4.xml","form_type":"4"}},{"id":4471384,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2017-02-02T20:08:59.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":26320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option becomes exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":26320,"derivative":{"exercise_price":27.48,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":26320},"source":{"system":"sec-edgar","filing":"0001209191-17-007330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117007330/doc4.xml","form_type":"4"}},{"id":4471383,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-02T20:08:59.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":11440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units awarded on January 31, 2017 which vest as to 1/3 of the shares on each of February 15, 2018, 2019 and 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 11,114 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":25049,"source":{"system":"sec-edgar","filing":"0001209191-17-007330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919117007330/doc4.xml","form_type":"4"}},{"id":4515582,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:14:08.000Z","date":"2016-08-15","kind":"tax_withholding","acquired":false,"shares":1066,"price":27,"value":28782.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 11,114 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":13241,"source":{"system":"sec-edgar","filing":"0001209191-16-156140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919116156140/doc4.xml","form_type":"4"}},{"id":4515581,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":10315,"kind":"person","name":"Febbo Phillip G.","position":1,"cik":"0001649245","reported_name":"Febbo Phillip G.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2016-12-20T17:14:08.000Z","date":"2015-08-15","kind":"tax_withholding","acquired":false,"shares":1065,"price":24.85,"value":26465.25,"ownership":{"direct":true},"balance_after":14307,"source":{"system":"sec-edgar","filing":"0001209191-16-156140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919116156140/doc4.xml","form_type":"4"}}]}